A comprehensive view of Non-Vaccine Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Lotte Biologics to invest US$3.0B by 2030 to build three mega plants in South Korea with total capacity of 360,000 liters of antibody drugs; commercial production to start in 2027 and all three plants to be fully operational by 2034
Published: January 27, 2023 by BioSpectrum Asia
Pfizer Listed a New Clinical Trial to Understand Long-term Safety and Effects of Fordadistrogene Movaparvovec Experimental Gene Therapy for Duchenne Muscular Dystrophy
Published: January 20, 2023 by Contify Life Science News
Merck wraps up US$1.35B deal for US-based Imago Biosciences; Imago to become wholly-owned subsidiary of Merck
Published: January 12, 2023 by SeeNews Deals
Autobahn Therapeutics announces initiation of a Phase 1 clinical trial of ABX-002 for the treatment for major depressive disorder; ABX-002 is a selective brain-boosting thyroid receptor beta agonist
Published: December 29, 2022 by Contify Life Science News
Pfizer, partnering with Sosei Group, announces dosing of first subject in Phase 2 clinical trial of PF-07081532, a candidate for treatment of type 2 diabetes and obesity; trial marks a development milestone, triggering US$10M payment to Sosei
Published: December 21, 2022 by Globe Newswire

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count